Crystallisation was never mentioned. The reason was based on a series of M&A's and nothing to do with inefficiencies of the drug.
- Forums
- ASX - By Stock
- RAC
- Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-28
-
-
- There are more pages in this discussion • 364 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
0.045(2.96%) |
Mkt cap ! $259.1M |
Open | High | Low | Value | Volume |
$1.56 | $1.57 | $1.56 | $4.454K | 2.864K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 426 | $1.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15 | 1.560 |
1 | 858 | 1.555 |
1 | 3300 | 1.550 |
1 | 5299 | 1.540 |
1 | 1138 | 1.535 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 4309 | 2 |
1.600 | 391 | 1 |
1.610 | 4503 | 1 |
1.620 | 192 | 1 |
1.650 | 347 | 1 |
Last trade - 10.27am 08/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online